| scholarly article | Q13442814 |
| P2093 | author name string | Jin Wang | |
| Yanli Zhang | |||
| Yanchuan Pu | |||
| Hulin Wang | |||
| Zicai Li | |||
| P2860 | cites work | Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics | Q26753032 |
| Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease | Q26765464 | ||
| Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program | Q33406382 | ||
| What do you mean, "epigenetic"? | Q35342673 | ||
| Long noncoding RNAs: a potential novel class of cancer biomarkers | Q38466810 | ||
| Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β-catenin pathway | Q39652903 | ||
| LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56. | Q42775109 | ||
| Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols | Q44438560 | ||
| Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth | Q47095623 | ||
| Long noncoding RNA NBAT1 negatively modulates growth and metastasis of osteosarcoma cells through suppression of miR-21. | Q47137873 | ||
| Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis | Q47369847 | ||
| LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway | Q47404465 | ||
| Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma | Q47426600 | ||
| Long Noncoding RNA: Genome Organization and Mechanism of Action | Q47942929 | ||
| lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition | Q47993457 | ||
| MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma. | Q49342996 | ||
| The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma. | Q49415492 | ||
| Long Non-Coding RNA XIST Promotes Osteosarcoma Progression by Targeting YAP via miR-195-5p. | Q49562833 | ||
| LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition. | Q49792268 | ||
| New insights into long noncoding RNAs and their roles in glioma. | Q49843574 | ||
| LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. | Q49922907 | ||
| Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression. | Q50045231 | ||
| Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration and invasion by regulating microRNA-21. | Q50091288 | ||
| Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. | Q51092483 | ||
| Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression. | Q51319727 | ||
| LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation. | Q52356912 | ||
| Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma. | Q52666444 | ||
| LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis. | Q53138924 | ||
| Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway. | Q54094189 | ||
| Knockdown of long non-coding RNA CAT104 inhibits the proliferation, migration and invasion of human osteosarcoma cells by regulating microRNA-381. | Q54122148 | ||
| Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. | Q54979199 | ||
| Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway. | Q55233564 | ||
| Molecular Mechanisms of Long Noncoding RNAs-medicated Cancer Metastasis | Q57802920 | ||
| Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma | Q58762367 | ||
| Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms | Q58766881 | ||
| LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma | Q64077526 | ||
| Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway | Q64079492 | ||
| Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b | Q64112826 | ||
| Integrative analysis reveals driver long non-coding RNAs in osteosarcoma | Q64257060 | ||
| LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells. | Q64899621 | ||
| LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis. | Q64987476 | ||
| Long non-coding RNA NEAT1 promotes proliferation, migration and invasion of human osteosarcoma cells. | Q65001390 | ||
| Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling. | Q65002307 | ||
| Osteogenic sarcoma with clinically detectable metastasis at initial presentation | Q70590738 | ||
| FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2 | Q88957472 | ||
| Long noncoding RNA LINC00858 promotes osteosarcoma through regulating miR-139-CDK14 axis | Q89259934 | ||
| Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma | Q89496256 | ||
| Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p | Q90476940 | ||
| ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2 | Q90513930 | ||
| SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma | Q90567400 | ||
| LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis | Q90719612 | ||
| Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells | Q90780618 | ||
| lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma | Q90788693 | ||
| LncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential | Q90972647 | ||
| Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223 | Q91006778 | ||
| Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis | Q91006928 | ||
| Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2 | Q91006942 | ||
| [Long non-coding RNA RAB11B-AS1 prevents osteosarcoma proliferation via its sense gene RAB11B] | Q91109186 | ||
| lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway | Q91129853 | ||
| LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3 | Q91146920 | ||
| Long noncoding RNAs: from genomic junk to rising stars in the early detection of cancer | Q91229629 | ||
| Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation | Q91291454 | ||
| Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro | Q91687133 | ||
| LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years | Q91810189 | ||
| Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling | Q91876098 | ||
| Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma | Q92066003 | ||
| LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway | Q92154193 | ||
| Correction: H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses | Q92483154 | ||
| Exosome-transferred lncRNAs at the core of cancer bone lesions | Q92486175 | ||
| LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma | Q92690958 | ||
| Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression | Q92903711 | ||
| LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression | Q92981943 | ||
| Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling | Q93028232 | ||
| Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma | Q93343037 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 2606-2612 | |
| P577 | publication date | 2020-07-03 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Research progress regarding the role of long non-coding RNAs in osteosarcoma | |
| P478 | volume | 20 |
Search more.